[James Boston]

I just glanced at a few things:

P/E is too high, so growth potential is probably factored in like you said.

P/S is the worst among it's competitors, and about 4x the industry, so they're priced well above what they're earning.

I think their future clientel is a decisive factor in what they're worth, and I don't think I'm clued in enough to accurately guess that. In February, it probably was a good buy, and it may still be. But as you pointed out, growth is already factored into their price, and I wouldn't feel good buying it.